Member of the Board since 2022.
BA in Community Health from Brown University and a Certificate in Premedical Sciences from Columbia University. Previous Research Associate at the New York University School of Medicine. Currently Managing Director, Therapeutics at Redmile Group, LLC. Born 1990.
Other board appointments: Hansa Biopharma AB, Redx Pharma Plc and Sensorion SA.
Shareholding: -